Vaish's Low‑Cost Cirrhosis Tool Gains Global Spotlight

Liver disease kills ~250,000 Indians annually, prompting urgent public‑health focus on affordable diagnostics and prognostics.
Dr. Udit Bhaskar Vaish proposes using routine NLR and APRI blood‑test indices for rapid, low‑cost cirrhosis severity assessment.
The methodology was selected for a podium presentation at the 24th European Congress of Internal Medicine (ECIM 2026) in Vienna, highlighting its scalability.
Investors may see increased demand for Indian healthcare providers, diagnostic labs, and equipment makers, potentially boosting sector equities.